Survival of ovarian cancer patients in Denmark: Excess mortality risk analysis of five-year relative survival in the period 1978-2002

Acta Obstetricia et Gynecologica Scandinavica

Volumn 87, Issue 12, 2008, Pages 1353-1360

  Hannibal, Charlotte Gerd ^a   Cortes, Rikke ^b   Engholm, Gerda ^b   Kjaer, Susanne Krüger ^a,c  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Cancer registry; Excess mortality risk analysis; Ovarian cancer; Population based

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DENMARK; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; CARCINOMA; DENMARK; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 57449120133     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340802483000     Document Type: Article

References (15)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Gatta G, Lasota MB, Verdecchia A. Survival of European women with gynaecological tumours, during the period 1978-1989. Eur J Cancer. 1998;34:2218-25.
3. Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol. 2003;101:885-91.
4. Balvert-Locht HR, Coebergh JW, Hop WC, Brolmann HA, Crommelin M, van Wijck DJ, et al. Improved prognosis of ovarian cancer in The Netherlands during the period 1975-1985: a registry-based study. Gynecol Oncol. 1991;42:3-8.
5. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, Version 2.0. Lyon: IARC Press; 2004.
6. Engholm G, Ferlay J, Christensen N, Bray F, Klint Å, Ólafsdóttir E, et al. NORDCAN: cancer incidence, mortality and prevalence in the Nordic countries, Version 3.2. Association of Nordic Cancer Registries. Danish Cancer Society (http://www.ancr.nu); 2008.
7. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002;38:99-166.
8. Kjaerbye-Thygesen A, Huusom LD, Frederiksen K, Kjaer SK. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries. Acta Obstet Gynecol Scand. 2005;84:1006-12.
9. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23:51-64.
10. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40:2307-16.
11. Bjorge T, Engeland A, Hansen S, Trope CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer. 1998;75:663-70.
12. Berrino F, De AR, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol. 2007;8:773-83.
13. Rosenthal AN, Menon U, Jacobs IJ. Screening for ovarian cancer. Clin Obstet Gynecol. 2006;49:433-47.
14. Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Moller TR, Storm HH, et al. Relative survival of cancer patients - a comparison between Denmark and the other Nordic countries. Acta Oncol. 1998;37:49-59.
15. Bjorge T, Engeland A, Hansen S, Trope CG. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. Int J Cancer. 1997;71:780-6.